Light Irrevocable Trust #1 dated April 22, 2019 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 4:15 pm Unchanged |
2024-12-31 | 13G | Design Therapeutics, Inc. DSGN |
Light Irrevocable Trust #1 dated April 22, 2019 | 3,834,355 6.900% |
0 (Unchanged) |
Filing |
| 2022-02-09 4:30 pm Purchase |
2021-12-31 | 13G | Design Therapeutics, Inc. DSGN |
Light Irrevocable Trust #1 dated April 22, 2019 | 3,834,355 6.900% |
3,834,355 (New Position) |
Filing |